P2RY12 and glaucoma: In a previous study, using this experimental model of glaucoma, we were able to prevent RGC death and the associated neuroinflammation (focused on morphological signs of microglial activation and on the expression of P2RY12) following the oral administration of saffron at the same dosage as that used in the current study [36].